BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16875922)

  • 1. Low voltage on the electrocardiogram is a marker of disease severity and a risk factor for adverse outcomes in patients with heart failure due to systolic dysfunction.
    Kamath SA; Meo Neto Jde P; Canham RM; Uddin F; Toto KH; Nelson LL; Kaiser PA; de Lemos JA; Drazner MH
    Am Heart J; 2006 Aug; 152(2):355-61. PubMed ID: 16875922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe frequent ventricular ectopy after exercise as a predictor of death in patients with heart failure.
    O'Neill JO; Young JB; Pothier CE; Lauer MS
    J Am Coll Cardiol; 2004 Aug; 44(4):820-6. PubMed ID: 15312865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remission of left ventricular systolic dysfunction and of heart failure symptoms after cardiac resynchronization therapy: temporal pattern and clinical predictors.
    Gasparini M; Regoli F; Ceriotti C; Galimberti P; Bragato R; De Vita S; Pini D; Andreuzzi B; Mangiavacchi M; Klersy C
    Am Heart J; 2008 Mar; 155(3):507-14. PubMed ID: 18294488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of the electrocardiographic strain pattern and albuminuria for the prediction of new-onset heart failure in hypertensive patients: the LIFE study.
    Okin PM; Wachtell K; Devereux RB; Nieminen MS; Oikarinen L; Viitasalo M; Toivonen L; Ibsen H; Olsen MH; Borch-Johnsen K; Lindholm LH; Kjeldsen SE; Julius S; Dahlöf B;
    Am J Hypertens; 2008 Mar; 21(3):273-9. PubMed ID: 18219298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic changes before acute heart failure episodes in patients with advanced systolic left ventricular dysfunction.
    Ghio S; Serio A; Mangiavacchi M; Kjellström B; Valsecchi S; Vicini I; Campana C; Gasparini M; Gronda E; Tavazzi L
    J Cardiovasc Med (Hagerstown); 2008 Aug; 9(8):799-804. PubMed ID: 18607244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart failure with preserved left ventricular systolic function among patients with non-ST-segment elevation acute coronary syndromes.
    Bennett KM; Hernandez AF; Chen AY; Mulgund J; Newby LK; Rumsfeld JS; Hochman JS; Hoekstra JW; Ohman EM; Gibler WB; Roe MT; Peterson ED
    Am J Cardiol; 2007 May; 99(10):1351-6. PubMed ID: 17493458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
    J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitral regurgitation in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: prognostic significance and relation to ventricular size and function.
    Amigoni M; Meris A; Thune JJ; Mangalat D; Skali H; Bourgoun M; Warnica JW; Barvik S; Arnold JM; Velazquez EJ; Van de Werf F; Ghali J; McMurray JJ; Køber L; Pfeffer MA; Solomon SD
    Eur Heart J; 2007 Feb; 28(3):326-33. PubMed ID: 17251259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry.
    Fonarow GC; Stough WG; Abraham WT; Albert NM; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy CW; Young JB;
    J Am Coll Cardiol; 2007 Aug; 50(8):768-77. PubMed ID: 17707182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total cholesterol levels and mortality risk in nonischemic systolic heart failure.
    Afsarmanesh N; Horwich TB; Fonarow GC
    Am Heart J; 2006 Dec; 152(6):1077-83. PubMed ID: 17161056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anemia and outcomes in patients with heart failure: a study from the National Heart Care Project.
    Kosiborod M; Curtis JP; Wang Y; Smith GL; Masoudi FA; Foody JM; Havranek EP; Krumholz HM
    Arch Intern Med; 2005 Oct; 165(19):2237-44. PubMed ID: 16246989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reverse epidemiology in systolic and nonsystolic heart failure: cumulative prognostic benefit of classical cardiovascular risk factors.
    Güder G; Frantz S; Bauersachs J; Allolio B; Wanner C; Koller MT; Ertl G; Angermann CE; Störk S
    Circ Heart Fail; 2009 Nov; 2(6):563-71. PubMed ID: 19919981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study.
    Salerno-Uriarte JA; De Ferrari GM; Klersy C; Pedretti RF; Tritto M; Sallusti L; Libero L; Pettinati G; Molon G; Curnis A; Occhetta E; Morandi F; Ferrero P; Accardi F;
    J Am Coll Cardiol; 2007 Nov; 50(19):1896-904. PubMed ID: 17980258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of improved left ventricular systolic function in an urban cardiomyopathy program.
    Sam F; Halickman I; Vita JA; Levitzky Y; Cupples LA; Loscalzo J; Allensworth-Davies D
    Am J Cardiol; 2006 Dec; 98(12):1622-6. PubMed ID: 17145222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of diabetes mellitus and ischemic heart disease on the progression from asymptomatic left ventricular dysfunction to symptomatic heart failure: a retrospective analysis from the Studies of Left Ventricular Dysfunction (SOLVD) Prevention trial.
    Das SR; Drazner MH; Yancy CW; Stevenson LW; Gersh BJ; Dries DL
    Am Heart J; 2004 Nov; 148(5):883-8. PubMed ID: 15523322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic value of BNP and cardiopulmonary exercise testing in patients with systolic heart failure on beta-blocker therapy].
    Pascual-Figal DA; Peñafiel P; Nicolas F; de la Morena G; Ansaldo P; Redondo B; Sánchez Mas J; Valdés M
    Rev Esp Cardiol; 2008 Mar; 61(3):260-8. PubMed ID: 18361899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and prognostic significance of elevated gamma-glutamyltransferase in chronic heart failure.
    Poelzl G; Eberl C; Achrainer H; Doerler J; Pachinger O; Frick M; Ulmer H
    Circ Heart Fail; 2009 Jul; 2(4):294-302. PubMed ID: 19808352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of depression to death or hospitalization in patients with heart failure.
    Sherwood A; Blumenthal JA; Trivedi R; Johnson KS; O'Connor CM; Adams KF; Dupree CS; Waugh RA; Bensimhon DR; Gaulden L; Christenson RH; Koch GG; Hinderliter AL
    Arch Intern Med; 2007 Feb; 167(4):367-73. PubMed ID: 17325298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central sleep apnea, right ventricular dysfunction, and low diastolic blood pressure are predictors of mortality in systolic heart failure.
    Javaheri S; Shukla R; Zeigler H; Wexler L
    J Am Coll Cardiol; 2007 May; 49(20):2028-34. PubMed ID: 17512359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of gender and etiology with outcomes in heart failure with systolic dysfunction: a pooled analysis of 5 randomized control trials.
    Frazier CG; Alexander KP; Newby LK; Anderson S; Iverson E; Packer M; Cohn J; Goldstein S; Douglas PS
    J Am Coll Cardiol; 2007 Apr; 49(13):1450-8. PubMed ID: 17397674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.